Press Releases

Press Releases

    Date Title View
    01/23/23
    Summary ToggleRule 17 (b) Announcement – Horizon Therapeutics plc
    PDF Version
    01/23/23
    Summary ToggleRule 17 (a) Announcement – Horizon Therapeutics plc
    PDF Version
    01/18/23
    Summary ToggleHorizon Therapeutics plc Announces Phase 2 Trial Evaluating Dazodalibep for the Treatment of Sjögren’s Syndrome Meets Primary Endpoint in the Second Study Population; Only Phase 2 Trial to Meet Primary Endpoint in Both Patient Populations
    PDF Version
    01/12/23
    Summary ToggleRule 2.12 Announcement – Horizon Therapeutics plc
    PDF Version
    01/06/23
    Summary ToggleRule 8.1 Dealing Disclosure (Horizon Therapeutics plc)
    01/06/23
    Summary ToggleRule 8.1 Dealing Disclosure (Horizon Therapeutics plc)
    01/06/23
    Summary ToggleRule 8.1 Dealing Disclosure (Horizon Therapeutics plc)
    01/06/23
    Summary ToggleRule 8.1 Dealing Disclosure (Horizon Therapeutics plc)
    01/04/23
    Summary ToggleRule 8.1 Dealing Disclosure (Horizon Therapeutics plc)
    01/04/23
    Summary ToggleHorizon Therapeutics plc Announces First Patient Enrolled in Phase 2 Trial Evaluating Daxdilimab for the Treatment of Discoid Lupus Erythematosus
    PDF Version
    Displaying 11 - 20 of 727 results